13.07.2021
А. Е. Каратеев; В. Н. Амирджанова; Е. Л. Насонов; А. М. Лила; Л. И. Алексеева; Е. Ю. Погожева; Е. С. Филатова; В. А. Нестеренко
Combating the consequences of COVID-19, a disease caused by the new coronavirus infection SARS-CoV
25.06.2021
Е. Л. Насонов; А. М. Лила; В. И. Мазуров; Б. С. Белов; А. Е. Каратеев; Т. В. Дубинина; О. А. Никитинская; А. А. Баранов; Д. И. Абдулганиева; С. В. Моисеев; А. И. Загребнева
the coronavirus disease (COVID-19) pandemic, affected more than 157 million people in all regions of the world
10.05.2021
Е. Л. Насонов; Т. В. Попкова; Т. А. Панафидина
of the transformation of “incomplete” SLE into “reliable” SLE, difficulties in diagnosing SLE during the COVID-19
02.03.2021
Е. Л. Насонов
The coronavirus 2019 pandemic (coronavirus disease, COVID-19), etiologically related to the SARS
24.02.2021
Е. Л. Насонов
The coronavirus 2019 pandemic (coronavirus disease, COVID-19), etiologically related to the SARS
09.11.2020
М. И. Каледа; И. П. Никишина; Е. С. Федоров; Е. Л. Насонов
The clinical presentation and outcomes of infection with the novel coronavirus (COVID-19
26.10.2020
Е. Л. Насонов
The coronavirus disease 2019 (COVID-19) pandemic has drawn attention to new clinical
03.09.2020
Е. Л. Насонов; Т. В. Бекетова; Т. М. Решетняк; А. М. Лила; Л. П. Ананьева; Т. А. Лисицина; С. К. Соловьев
, caused by SARS-Cov-2 (severe acute respiratory syndrome Coronavirus-2). COVID-19 is considered currently
24.06.2020
А. Е. Каратеев; Е. Л. Насонов; А. М. Лила
-steroidal anti-inflammatory drugs (NSAIDs), and in particular ibuprofen, for COVID-19 infection
23.06.2020
Е. Л. Насонов
The Coronavirus Disease 2019 (COVID-19) pandemic has drawn closer attention than ever before
